Anika Therapeutics (ANIK) Inventory Average (2011 - 2026)
Anika Therapeutics (ANIK) posted quarterly Inventory Average of $25.7 million for Q2 2026, up 34.36% year-over-year from $19.1 million in Q2 2025, and up 23.49% quarter-over-quarter from $20.8 million in Q1 2026.
Anika Therapeutics (ANIK) Inventory Average (2011 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Inventory Average for 16 consecutive years, with $25.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Inventory Average rose 34.36% year-over-year to $25.7 million; the TTM figure through Jun 2026 stood at $25.7 million (up 34.36% YoY), while the FY2025 annual figure was $21.3 million, down 11.69% from the prior year.
- Inventory Average improved to $25.7 million in Q2 2026 per ANIK's latest filing, from $20.8 million in the prior quarter.
- Across five years, Inventory Average topped out at $50.4 million in Q2 2024 and bottomed at $16.6 million in Q3 2025.
- Historically, Inventory Average has averaged $32.9 million across 5 years, with a median of $35.4 million in 2022.
- Annual changes were most pronounced in 2025 — Inventory Average slumped 63.55% — and 2026, when it soared 34.36%.
- Anika Therapeutics' Inventory Average stood at $38.5 million in 2022, then dropped by 11.49% to $34.1 million in 2023, then slipped by 6.92% to $31.7 million in 2024, then tumbled by 44.72% to $17.5 million in 2025, then surged by 46.57% to $25.7 million in 2026.
- Business Quant data shows ANIK's Inventory Average at $25.7 million in Q2 2026, $20.8 million in Q1 2026, and $17.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Anika Therapeutics | 284.33 Mn | 245.92 Mn | 21.24 Mn | 25.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.70 Mn |
| Mar 31, 2026 | 20.81 Mn |
| Dec 31, 2025 | 17.54 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Jun 30, 2025 | 19.13 Mn |
| Mar 31, 2025 | 22.57 Mn |
| Dec 31, 2024 | 31.72 Mn |
| Sep 30, 2024 | 45.55 Mn |
| Jun 30, 2024 | 50.44 Mn |
| Mar 31, 2024 | 36.92 Mn |
| Dec 31, 2023 | 34.08 Mn |
| Sep 30, 2023 | 43.16 Mn |
| Jun 30, 2023 | 41.96 Mn |
| Mar 31, 2023 | 40.54 Mn |
| Dec 31, 2022 | 38.50 Mn |
| Sep 30, 2022 | 36.29 Mn |
| Jun 30, 2022 | 35.28 Mn |
| Mar 31, 2022 | 35.62 Mn |
| Dec 31, 2021 | 35.51 Mn |
| Sep 30, 2021 | 38.94 Mn |